Syra Health

SYRA · OTC

$0.83+$0.0042 (+0.51%)TodayMarket closed ·
Prev close $0.8258

About SYRA

Syra Health Corp. operates as a medical technology company, which engages in developing end-to-end solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce. The company is headquartered in Carmel, Indiana and currently employs 38 full-time employees. The company went IPO on 2023-09-29. The company offers Syrenity, which is a comprehensive mental health application that helps in providing preventative care and interventions for behavioral and mental health and utilizes an artificial intelligence-driven user diary for engagement. Its solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Within its population health service line, it offers various services, including analytics as a service, epidemiology, and health equity analytics solutions. The company provides medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, government agencies, and others. Within its health education service line, it offers various services, such as medical communications, patient education, and healthcare training.

Employees
38
Headquarters
Carmel, Indiana
Listed
Sep 29, 2023
Sector
Health Care
Industry
Health Care Providers & Services

SYRA key statistics

Market cap
11.79M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
21.47K
Volume
3.13K
Open price
$0.83
High today
$0.83
Low today
$0.8288
52 Week high
$1.15
52 Week low
$0.0556

Syra Health (SYRA) at a glance

Syra Health (SYRA) last traded at $0.83, with a market cap of 11.79M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.8288 and $0.83. The current price is 0.1% above the day's low and 0.0% below its high.

Volume so far is 3.13K shares, below the average of 21.47K shares a day.

Over the past year Syra Health has ranged from $0.0556 to $1.15, and now sits 71% of the way up that range.

Syra Health met or beat analyst EPS estimates in 1 of the last 4 quarters. In Q3 FY24 it reported -$0.06 per share against an estimate of -$0.2142.

SYRA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 4 quarters, by 72.0% on average.

  1. Q4 FY23: reported -$0.16 per share against an estimate of -$0.0918
  2. Q1 FY24: reported -$0.22 per share against an estimate of -$0.1938
  3. Q2 FY24: reported -$0.21 per share against an estimate of -$0.1938
  4. Q3 FY24: reported -$0.06 per share against an estimate of -$0.2142

SYRA news

  • Press releasePRNewswire

    Syra Health Awarded Three-Year Public Health Analytics Contract with Mississippi State Department of Health

  • Press releasePRNewswire

    Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

  • Press releasePRNewswire

    Syra Health, Wake County Public Health Expand Wellness Partnership

  • Press releasePRNewswire

    Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

  • Press releasePRNewswire

    Syra Health To Announce Second Quarter 2026 Financial Results

  • Press releasePRNewswire

    Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

  • Press releasePRNewswire

    Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position

  • Press releasePRNewswire

    Syra Health To Announce First Quarter 2026 Financial Results

Similar companies

Companies in the same industry as Syra Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.